首页 › 基金 › Defilade Capital Management, L.P. › GKOS
Defilade Capital Management, L.P. 对 GKOS 的持仓历史
GLAUKOS CORP · 医疗保健
Defilade Capital Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 GKOS(GLAUKOS CORP)66,519 股,市值约 US$9.3M,约占其申报组合的 1.24%,在其申报持仓中市值排名第 33 位。 Defilade Capital Management, L.P. 最近 3 个申报季度中有 2 个季度披露了 GKOS 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Defilade Capital Management, L.P. 对 GKOS 的持仓演变
Defilade Capital Management, L.P. 于 Q4 2025 首次披露 GKOS 持仓:91,703 股(约 US$10.4M)。 在 2 次申报中,Defilade Capital Management, L.P. 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 66,519 股、市值约 US$9.3M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 91.70K | $10.35M | 新进 |
| Q2 2026 | 66.52K | $9.30M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GKOS 与 13F 数据
GKOS(GLAUKOS CORP)属于医疗保健行业。我们追踪的基金中还有 45 只申报持有 GKOS,申报仓位最大的包括:BRAIDWELL LP (US$82.7M), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$62.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GKOS 的基金
- BRAIDWELL LP 591.93K 股 · $82.73M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 446.55K 股 · $62.41M · Q2 2026
更多关于 Defilade Capital Management, L.P.
常见问题
How long has Defilade Capital Management, L.P. held GKOS?
Defilade Capital Management, L.P. has disclosed GKOS holdings in 2 of the last 3 reported quarters, going back to Q4 2025.
What is Defilade Capital Management, L.P.'s current position in GKOS?
As of Q2 2026, Defilade Capital Management, L.P. holds 66.52K shares of GKOS (GLAUKOS CORP), valued at $9.30M, representing 1.24% of its reported portfolio and ranking #33.
Has Defilade Capital Management, L.P. been buying or selling GKOS?
In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. newly opened its position in GKOS.
Which other funds hold GKOS?
Other major institutional holders of GKOS include BRAIDWELL LP, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.